title: High-density lipoprotein function in rheumatoid arthritis.
abstract: OBJECTIVE
  Patients with rheumatoid arthritis (RA) have accelerated atherosclerosis despite the appearance of having a less atherogenic lipid profile; however, lipoprotein function rather than concentration may be a better indicator of atherosclerotic risk. The purpose of this review is to summarize recent findings concerning HDL function in patients with RA.
  
  
  RESULTS
  Two major activities of HDL, its antioxidant and cholesterol efflux functions have been examined in RA. HDL antioxidant capacity is inversely associated with inflammation and RA disease activity; however, there is no clear consensus if antioxidant capacity is altered significantly in RA compared with control study participants. Moreover, despite numerous studies there is no consensus whether HDL cholesterol efflux capacity is significantly altered in RA compared with control study participants or influenced by inflammation or disease activity.
  
  
  CONCLUSIONS
  Additional studies will be valuable to consolidate existing data and find consensus. Moreover, studies evaluating the impact of various HDL functions on cardiovascular disease in RA are needed.
authors.affiliation: Vanderbilt University Medical Center, Nashville, Tennessee, USA.
authors.forename: Michelle J
authors.initials: MJ
authors.lastname: Ormseth
authors.forename: C Michael
authors.initials: CM
authors.lastname: Stein
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000378:metabolism; D006801:Humans; D008075:Lipoproteins, HDL / Q000378:metabolism*
chemical_list: D000975:Antioxidants; D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL